Changmao Biochemical Engineering Company Limited (HKG:0954)

HKG:0954 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	68.15	57.96	89.55	59.99	58.63
Short-Term Investments	3.65	16.6	7	3.64	-
Cash & Short-Term Investments	71.8	74.57	96.56	63.63	58.63
Cash Growth	-3.71%	-22.78%	51.75%	8.53%	-56.36%
Accounts Receivable	75.49	63	87.94	75.42	87.84
Other Receivables	6.2	11.41	13.87	42.15	27.38
Receivables	81.69	74.41	101.8	117.57	115.22
Inventory	110.36	143.35	132.08	160.91	122.9
Prepaid Expenses	7.21	5.35	6.27	-	-
Restricted Cash	-	1.11	1.61	12.34	14.75
Other Current Assets	-	0.01	-	7.59	5.53
Total Current Assets	271.05	298.79	338.32	362.05	317.03
Property, Plant & Equipment	886.36	924.98	865.86	773.42	597.56
Other Intangible Assets	0.37	0.51	0.64	0.77	1.02
Long-Term Deferred Tax Assets	-	0.22	0.68	24.65	20.49
Other Long-Term Assets	21.94	25.26	37	45.86	20.42
Total Assets	1,180	1,250	1,242	1,207	956.52

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	25.99	28.7	30.77	66.54	95.81
Accrued Expenses	6.52	5.96	10.89	21.04	8.38
Short-Term Debt	207.57	282.63	54.65	103.9	78.4
Current Portion of Long-Term Debt	220.08	232.11	187.55	33.64	8.5
Current Portion of Leases	50.89	0.68	0.96	0.68	0.58
Current Income Taxes Payable	1.57	1.54	2.16	3.31	6.4
Current Unearned Revenue	4.99	7.52	5.16	6.28	8.36
Other Current Liabilities	29.89	45.42	33.09	38.63	50.3
Total Current Liabilities	547.49	604.55	325.24	274.02	256.71
Long-Term Debt	60.32	20.3	250.41	152.07	1.5
Long-Term Leases	0.22	0.42	1.07	1.21	0.27
Long-Term Unearned Revenue	54.78	40.47	13.58	0.04	0.06
Long-Term Deferred Tax Liabilities	0.74	0.68	0.6	0.53	0.45
Total Liabilities	663.56	666.42	590.91	427.86	258.99

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	52.97	52.97	52.97	52.97	52.97
Additional Paid-In Capital	102.56	102.56	102.56	102.56	102.56
Retained Earnings	358.75	426.29	494.65	622.54	541.11
Comprehensive Income & Other	2.41	1.63	1.51	0.47	0.46
Total Common Equity	516.68	583.45	651.69	778.53	697.1
Minority Interest	-0.51	-0.11	-0.1	0.36	0.43
Shareholders' Equity	516.17	583.34	651.59	778.89	697.53
Total Liabilities & Equity	1,180	1,250	1,242	1,207	956.52

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	539.07	536.13	494.65	291.5	89.26
Net Cash (Debt)	-467.27	-461.57	-398.09	-227.87	-30.63
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.88	-0.87	-0.75	-0.43	-0.06
Filing Date Shares Outstanding	529.7	529.7	529.7	529.7	529.7
Total Common Shares Outstanding	529.7	529.7	529.7	529.7	529.7
Working Capital	-276.44	-305.76	13.08	88.03	60.31
Book Value Per Share	0.98	1.10	1.23	1.47	1.32
Tangible Book Value	516.31	582.94	651.05	777.76	696.08
Tangible Book Value Per Share	0.97	1.10	1.23	1.47	1.31
Buildings	461.06	401.76	289.52	273.77	210.9
Machinery	730.67	640.92	543.86	482.6	399.21
Construction In Progress	90.68	230.34	339.05	250.54	211.16

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 4, 2026

Data Sources Report a data error